miércoles, 13 de octubre de 2021

Opportunity for Public Comment | United States Preventive Services Taskforce | *CORRECTION* Comment on Draft Recommendation Statement, Draft Evidence Review, and Draft Modeling Report: Aspirin Use to Prevent Cardiovascular Disease

Opportunity for Public Comment | United States Preventive Services Taskforce

No hay comentarios: